<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Intensive Care</journal-id><journal-id journal-id-type="iso-abbrev">J Intensive Care</journal-id><journal-title-group><journal-title>Journal of Intensive Care</journal-title></journal-title-group><issn pub-type="epub">2052-0492</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31938547</article-id><article-id pub-id-type="pmc">6954566</article-id><article-id pub-id-type="publisher-id">426</article-id><article-id pub-id-type="doi">10.1186/s40560-020-0426-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Risk modifiers of acute respiratory distress syndrome in patients with non-pulmonary sepsis: a retrospective analysis of the FORECAST study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Iriyama</surname><given-names>Hiroki</given-names></name><address><email>iriyamahiroki@yahoo.co.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Abe</surname><given-names>Toshikazu</given-names></name><address><email>abetoshi111@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Kushimoto</surname><given-names>Shigeki</given-names></name><address><email>kussie@emergency-medicine.med.tohoku.ac.jp</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Fujishima</surname><given-names>Seitaro</given-names></name><address><email>fujishim@keio.jp</email></address><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Ogura</surname><given-names>Hiroshi</given-names></name><address><email>ogura@hp-emerg.med.osaka-u.ac.jp</email></address><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Shiraishi</surname><given-names>Atsushi</given-names></name><address><email>siris.accm@tmd.ac.jp</email></address><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Saitoh</surname><given-names>Daizoh</given-names></name><address><email>ds0711@ndmc.ac.jp</email></address><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Mayumi</surname><given-names>Toshihiko</given-names></name><address><email>mtoshi@med.uoeh-u.ac.jp</email></address><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Naito</surname><given-names>Toshio</given-names></name><address><email>natio@juntendo.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Komori</surname><given-names>Akira</given-names></name><address><email>akg.6412@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hifumi</surname><given-names>Toru</given-names></name><address><email>hifumitoru@gmail.com</email></address><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Shiino</surname><given-names>Yasukazu</given-names></name><address><email>shiino@me.com</email></address><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Nakada</surname><given-names>Taka-aki</given-names></name><address><email>taka.nakada@nifty.com</email></address><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name><surname>Tarui</surname><given-names>Takehiko</given-names></name><address><email>tarui@ks.kyorin-u.ac.jp</email></address><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name><surname>Otomo</surname><given-names>Yasuhiro</given-names></name><address><email>otomo.accm@tmd.ac.jp</email></address><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name><surname>Okamoto</surname><given-names>Kohji</given-names></name><address><email>kohji.okamot@gmail.com</email></address><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author"><name><surname>Umemura</surname><given-names>Yutaka</given-names></name><address><email>plum0022@yahoo.co.jp</email></address><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Kotani</surname><given-names>Joji</given-names></name><address><email>kotanijo0412@gmail.com</email></address><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name><surname>Sakamoto</surname><given-names>Yuichiro</given-names></name><address><email>sakamoy@cc.saga-u.ac.jp</email></address><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name><surname>Sasaki</surname><given-names>Junichi</given-names></name><address><email>sasakij@1989.jukuin.keio.ac.jp</email></address><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name><surname>Shiraishi</surname><given-names>Shin-ichiro</given-names></name><address><email>shinshi@nms.ac.jp</email></address><xref ref-type="aff" rid="Aff19">19</xref></contrib><contrib contrib-type="author"><name><surname>Takuma</surname><given-names>Kiyotsugu</given-names></name><address><email>drtakumaphd@fa2.so-net.ne.jp</email></address><xref ref-type="aff" rid="Aff20">20</xref></contrib><contrib contrib-type="author"><name><surname>Tsuruta</surname><given-names>Ryosuke</given-names></name><address><email>tsurutar@yamaguchi-u.ac.jp</email></address><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name><surname>Hagiwara</surname><given-names>Akiyoshi</given-names></name><address><email>ahagiwar@hosp.ncgm.go.jp</email></address><xref ref-type="aff" rid="Aff22">22</xref></contrib><contrib contrib-type="author"><name><surname>Yamakawa</surname><given-names>Kazuma</given-names></name><address><email>k.yamakawa0911@gmail.com</email></address><xref ref-type="aff" rid="Aff23">23</xref></contrib><contrib contrib-type="author"><name><surname>Masuno</surname><given-names>Tomohiko</given-names></name><address><email>masuno@nms.ac.jp</email></address><xref ref-type="aff" rid="Aff24">24</xref></contrib><contrib contrib-type="author"><name><surname>Takeyama</surname><given-names>Naoshi</given-names></name><address><email>takeyama@aichi-med-u.ac.jp</email></address><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><name><surname>Yamashita</surname><given-names>Norio</given-names></name><address><email>norio22@med.kurume-u.ac.jp</email></address><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name><surname>Ikeda</surname><given-names>Hiroto</given-names></name><address><email>ikeda@med.teikyo-u.ac.jp</email></address><xref ref-type="aff" rid="Aff27">27</xref></contrib><contrib contrib-type="author"><name><surname>Ueyama</surname><given-names>Masashi</given-names></name><address><email>m.ueyama@gmail.com</email></address><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name><surname>Fujimi</surname><given-names>Satoshi</given-names></name><address><email>sfujimi40@nifty.com</email></address><xref ref-type="aff" rid="Aff23">23</xref></contrib><contrib contrib-type="author"><name><surname>Gando</surname><given-names>Satoshi</given-names></name><address><email>gandoicoud@icloud.com</email></address><xref ref-type="aff" rid="Aff29">29</xref><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><collab>on behalf of JAAM FORECAST group<contrib-group><contrib contrib-type="author"><name><surname>Tasaki</surname><given-names>Osamu</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mizobata</surname><given-names>Yasumitsu</given-names></name></contrib><contrib contrib-type="author"><name><surname>Funakoshi</surname><given-names>Hiraku</given-names></name></contrib><contrib contrib-type="author"><name><surname>Okuyama</surname><given-names>Toshiro</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yamashita</surname><given-names>Iwao</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kanai</surname><given-names>Toshio</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yamada</surname><given-names>Yasuo</given-names></name></contrib><contrib contrib-type="author"><name><surname>Aibiki</surname><given-names>Mayuki</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sato</surname><given-names>Keiji</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yamashita</surname><given-names>Susumu</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yamashita</surname><given-names>Susumu</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yoshida</surname><given-names>Kenichi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kasaoka</surname><given-names>Shunji</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kon</surname><given-names>Akihide</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rinka</surname><given-names>Hiroshi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kato</surname><given-names>Hiroshi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Okudera</surname><given-names>Hiroshi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Narimatsu</surname><given-names>Eichi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Fujiwara</surname><given-names>Toshifumi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sugita</surname><given-names>Manabu</given-names></name></contrib><contrib contrib-type="author"><name><surname>Shichinohe</surname><given-names>Yasuo</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nakae</surname><given-names>Hajime</given-names></name></contrib><contrib contrib-type="author"><name><surname>Iiduka</surname><given-names>Ryouji</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nakamura</surname><given-names>Mitsunobu</given-names></name></contrib><contrib contrib-type="author"><name><surname>Murata</surname><given-names>Yuji</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sato</surname><given-names>Yoshitake</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ishikura</surname><given-names>Hiroyasu</given-names></name></contrib><contrib contrib-type="author"><name><surname>Myojo</surname><given-names>Yasuhiro</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tsujita</surname><given-names>Yasuyuki</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kinoshita</surname><given-names>Kosaku</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yamaguchi</surname><given-names>Hiroyuki</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sakurai</surname><given-names>Toshihiro</given-names></name></contrib><contrib contrib-type="author"><name><surname>Miyatake</surname><given-names>Satoru</given-names></name></contrib><contrib contrib-type="author"><name><surname>Saotome</surname><given-names>Takao</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yasuda</surname><given-names>Susumu</given-names></name></contrib><contrib contrib-type="author"><name><surname>Abe</surname><given-names>Toshikazu</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ogura</surname><given-names>Hiroshi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Umemura</surname><given-names>Yutaka</given-names></name></contrib><contrib contrib-type="author"><name><surname>Shiraishi</surname><given-names>Atsushi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kushimoto</surname><given-names>Shigeki</given-names></name></contrib><contrib contrib-type="author"><name><surname>Saitoh</surname><given-names>Daizoh</given-names></name></contrib><contrib contrib-type="author"><name><surname>Fujishima</surname><given-names>Seitaro</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sasaki</surname><given-names>Junichi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mayumi</surname><given-names>Toshihiko</given-names></name></contrib><contrib contrib-type="author"><name><surname>Shiino</surname><given-names>Yasukazu</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nakada</surname><given-names>Taka-aki</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tarui</surname><given-names>Takehiko</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hifumi</surname><given-names>Toru</given-names></name></contrib><contrib contrib-type="author"><name><surname>Otomo</surname><given-names>Yasuhiro</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kotani</surname><given-names>Joji</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sakamoto</surname><given-names>Yuichiro</given-names></name></contrib><contrib contrib-type="author"><name><surname>Shiraishi</surname><given-names>Shin-ichiro</given-names></name></contrib><contrib contrib-type="author"><name><surname>Takuma</surname><given-names>Kiyotsugu</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tsuruta</surname><given-names>Ryosuke</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hagiwara</surname><given-names>Akiyoshi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yamakawa</surname><given-names>Kazuma</given-names></name></contrib><contrib contrib-type="author"><name><surname>Takeyama</surname><given-names>Naoshi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yamashita</surname><given-names>Norio</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ikeda</surname><given-names>Hiroto</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mizushima</surname><given-names>Yasuaki</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gando</surname><given-names>Satoshi</given-names></name></contrib></contrib-group></collab><address><email>jaam-6@bz04.plala.or.jp</email></address></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1762 2738</institution-id><institution-id institution-id-type="GRID">grid.258269.2</institution-id><institution>Department of General Medicine, </institution><institution>Juntendo University, </institution></institution-wrap>2-1-1 Hongo, 103 Bunkyo-ku, Tokyo, 113-0033 Japan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2369 4728</institution-id><institution-id institution-id-type="GRID">grid.20515.33</institution-id><institution>Health Services Research and Development Center, </institution><institution>University of Tsukuba, </institution></institution-wrap>Tsukuba, Japan </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2369 4728</institution-id><institution-id institution-id-type="GRID">grid.20515.33</institution-id><institution>Department of Health Services Research, Faculty of Medicine, </institution><institution>University of Tsukuba, </institution></institution-wrap>Tsukuba, Japan </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2248 6943</institution-id><institution-id institution-id-type="GRID">grid.69566.3a</institution-id><institution>Division of Emergency and Critical Care Medicine, </institution><institution>Tohoku University Graduate School of Medicine, </institution></institution-wrap>Sendai, Japan </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 9959</institution-id><institution-id institution-id-type="GRID">grid.26091.3c</institution-id><institution>Center for General Medicine Education, </institution><institution>Keio University School of Medicine, </institution></institution-wrap>Tokyo, Japan </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0373 3971</institution-id><institution-id institution-id-type="GRID">grid.136593.b</institution-id><institution>Department of Traumatology and Acute Critical Medicine, </institution><institution>Osaka University Graduate School of Medicine, </institution></institution-wrap>Suita, Japan </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0378 2140</institution-id><institution-id institution-id-type="GRID">grid.414927.d</institution-id><institution>Emergency and Trauma Center, </institution><institution>Kameda Medical Center, </institution></institution-wrap>Kamogawa, Japan </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0374 0880</institution-id><institution-id institution-id-type="GRID">grid.416614.0</institution-id><institution>Division of Traumatology, </institution><institution>Research Institute, National Defense Medical College, </institution></institution-wrap>Tokyo, Japan </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0374 5913</institution-id><institution-id institution-id-type="GRID">grid.271052.3</institution-id><institution>Department of Emergency Medicine, School of Medicine, </institution><institution>University of Occupational and Environmental Health, </institution></institution-wrap>Kitakyushu, Japan </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.430395.8</institution-id><institution>Department of Emergency and Critical Care Medicine, </institution><institution>St. Luke&#x02019;s International Hospital, </institution></institution-wrap>Tokyo, Japan </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1014 2000</institution-id><institution-id institution-id-type="GRID">grid.415086.e</institution-id><institution>Department of Acute Medicine, </institution><institution>Kawasaki Medical School, </institution></institution-wrap>Kurashiki, Japan </aff><aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0370 1101</institution-id><institution-id institution-id-type="GRID">grid.136304.3</institution-id><institution>Department of Emergency and Critical Care Medicine, </institution><institution>Chiba University Graduate School of Medicine, </institution></institution-wrap>Chiba, Japan </aff><aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9340 2869</institution-id><institution-id institution-id-type="GRID">grid.411205.3</institution-id><institution>Department of Trauma and Critical Care Medicine, </institution><institution>Kyorin University School of Medicine, </institution></institution-wrap>Mitaka, Japan </aff><aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1014 9130</institution-id><institution-id institution-id-type="GRID">grid.265073.5</institution-id><institution>Trauma and Acute Critical Care Center, Medical Hospital, </institution><institution>Tokyo Medical and Dental University, </institution></institution-wrap>Tokyo, Japan </aff><aff id="Aff15"><label>15</label>Department of Surgery, Center for Gastroenterology and Liver Disease, Kitakyushu City Yahata Hospital, Kitakyushu, Japan </aff><aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1092 3077</institution-id><institution-id institution-id-type="GRID">grid.31432.37</institution-id><institution>Department of Disaster and Emergency Medicine, </institution><institution>Kobe University Graduate School of Medicine, </institution></institution-wrap>Kobe, Japan </aff><aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="GRID">grid.416518.f</institution-id><institution>Emergency and Critical Care Medicine, </institution><institution>Saga University Hospital, </institution></institution-wrap>Saga, Japan </aff><aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 9959</institution-id><institution-id institution-id-type="GRID">grid.26091.3c</institution-id><institution>Department of Emergency and Critical Care Medicine, </institution><institution>Keio University School of Medicine, </institution></institution-wrap>Tokyo, Japan </aff><aff id="Aff19"><label>19</label>Department of Emergency and Critical Care Medicine, Aizu Chuo Hospital, Aizuwakamatsu, Japan </aff><aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1772 6908</institution-id><institution-id institution-id-type="GRID">grid.415107.6</institution-id><institution>Emergency &#x00026; Critical Care Center, </institution><institution>Kawasaki Municipal Kawasaki Hospital, </institution></institution-wrap>Kawasaki, Japan </aff><aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="GRID">grid.413010.7</institution-id><institution>Advanced Medical Emergency &#x00026; Critical Care Center, </institution><institution>Yamaguchi University Hospital, </institution></institution-wrap>Ube, Japan </aff><aff id="Aff22"><label>22</label>Department of Emergency Medicine, Niizashiki Chuo General Hospital, Niiza, Japan </aff><aff id="Aff23"><label>23</label>Division of Trauma and Surgical Critical Care, Osaka General Medical Center, Osaka, Japan </aff><aff id="Aff24"><label>24</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2173 8328</institution-id><institution-id institution-id-type="GRID">grid.410821.e</institution-id><institution>Department of Emergency and Critical Care Medicine, </institution><institution>Nippon Medical School, </institution></institution-wrap>Tokyo, Japan </aff><aff id="Aff25"><label>25</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0727 1557</institution-id><institution-id institution-id-type="GRID">grid.411234.1</institution-id><institution>Advanced Critical Care Center, </institution><institution>Aichi Medical University Hospital, </institution></institution-wrap>Nagakute, Japan </aff><aff id="Aff26"><label>26</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1760 3449</institution-id><institution-id institution-id-type="GRID">grid.470127.7</institution-id><institution>Advanced Emergency Medical Service Center, </institution><institution>Kurume University Hospital, </institution></institution-wrap>Kurume, Japan </aff><aff id="Aff27"><label>27</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9239 9995</institution-id><institution-id institution-id-type="GRID">grid.264706.1</institution-id><institution>Department of Emergency Medicine, </institution><institution>Teikyo University School of Medicine, </institution></institution-wrap>Tokyo, Japan </aff><aff id="Aff28"><label>28</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0377 9435</institution-id><institution-id institution-id-type="GRID">grid.414470.2</institution-id><institution>Department of Trauma, Critical Care Medicine, and Burn Center, </institution><institution>Japan Community Healthcare Organization, Chukyo Hospital, </institution></institution-wrap>Nagoya, Japan </aff><aff id="Aff29"><label>29</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2173 7691</institution-id><institution-id institution-id-type="GRID">grid.39158.36</institution-id><institution>Division of Acute and Critical Care Medicine, </institution><institution>Hokkaido University Graduate School of Medicine, </institution></institution-wrap>Sapporo, Japan </aff><aff id="Aff30"><label>30</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1763 9791</institution-id><institution-id institution-id-type="GRID">grid.490419.1</institution-id><institution>Department of Acute and Critical Care Medicine, </institution><institution>Sapporo Higashi Tokushukai Hospital, </institution></institution-wrap>Sapporo, Japan </aff></contrib-group><pub-date pub-type="epub"><day>10</day><month>1</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>10</day><month>1</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>8</volume><elocation-id>7</elocation-id><history><date date-type="received"><day>27</day><month>9</month><year>2019</year></date><date date-type="accepted"><day>1</day><month>1</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2020</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Predisposing conditions and risk modifiers instead of causes and risk factors have recently been used as alternatives to identify patients at a risk of acute respiratory distress syndrome (ARDS). However, data regarding risk modifiers among patients with non-pulmonary sepsis is rare.</p></sec><sec><title>Methods</title><p id="Par2">We conducted a secondary analysis of the multicenter, prospective, Focused Outcomes Research in Emergency Care in Acute Respiratory Distress Syndrome, Sepsis and Trauma (FORECAST) cohort study that was conducted in 59 intensive care units (ICUs) in Japan during January 2016&#x02013;March 2017. Adult patients with severe sepsis caused by non-pulmonary infection were included, and the primary outcome was having ARDS, defined as meeting the Berlin definition on the first or fourth day of screening. Multivariate logistic regression modeling was used to identify risk modifiers associated with ARDS, and odds ratios (ORs) and their 95% confidence intervals were reported. The following explanatory variables were then assessed: age, sex, admission source, body mass index, smoking status, congestive heart failure, chronic obstructive pulmonary disease, diabetes mellitus, steroid use, statin use, infection site, septic shock, and acute physiology and chronic health evaluation (APACHE) II score.</p></sec><sec><title>Results</title><p id="Par3">After applying inclusion and exclusion criteria, 594 patients with non-pulmonary sepsis were enrolled, among whom 85 (14.3%) had ARDS. Septic shock was diagnosed in 80% of patients with ARDS and 66% of those without ARDS (<italic>p</italic> = 0.01). APACHE II scores were higher in patients with ARDS [26 (22&#x02013;33)] than in those without ARDS [21 (16&#x02013;28), <italic>p</italic> &#x0003c; 0.01]. In the multivariate logistic regression model, the following were independently associated with ARDS: ICU admission source [OR, 1.89 (1.06&#x02013;3.40) for emergency department compared with hospital wards], smoking status [OR, 0.18 (0.06&#x02013;0.59) for current smoking compared with never smoked], infection site [OR, 2.39 (1.04&#x02013;5.40) for soft tissue infection compared with abdominal infection], and APACHE II score [OR, 1.08 (1.05&#x02013;1.12) for higher compared with lower score].</p></sec><sec><title>Conclusions</title><p id="Par4">Soft tissue infection, ICU admission from an emergency department, and a higher APACHE II score appear to be the risk modifiers of ARDS in patients with non-pulmonary sepsis.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Acute respiratory distress syndrome</kwd><kwd>acute respiratory failure</kwd><kwd>sepsis</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par15">Acute respiratory distress syndrome (ARDS) comprises heterogenous clinical conditions. Reportedly, the prognosis of ARDS is poor [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>], and once a patient develops ARDS, treatment options are limited to only a few supportive strategies [<xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR9">9</xref>], making it important to identify patients at a high risk of ARDS [<xref ref-type="bibr" rid="CR10">10</xref>]. Previous studies have reported a variety of causes and risk factors of ARDS [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]; however, there is a lack of clarity between these because only a small proportion of patients with these causes and risk factors develop ARDS [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Therefore, alternative efforts have been recently focusing on the roles of two types of risk factors: predisposing conditions and risk modifiers [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Predisposing conditions are preceding acute pathophysiological events, such as sepsis. Risk modifiers include obesity [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>], smoking status [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>], diabetes mellitus (DM) (reduced risk modifier) [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR19">19</xref>], glucocorticoids [<xref ref-type="bibr" rid="CR20">20</xref>], statin [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>], non-pulmonary infection (reduced risk modifier) [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR23">23</xref>], shock [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR15">15</xref>], tachypnea [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>], oxygen supplementation [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR24">24</xref>], hematocrit [<xref ref-type="bibr" rid="CR11">11</xref>], hypoalbuminemia [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>], acidemia [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR15">15</xref>], and disease severity [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. There is a possibility that ARDS may be precisely predicted using a combination of predisposing conditions and risk modifiers.</p><p id="Par16">ARDS has been associated with two major pathophysiologic changes in various proportions. One is the influx of protein-rich effusion to the alveolar space caused by the damage of the local alveolar epithelium and another is leakage to the pulmonary interstitium through the capillary endothelium caused by systemic inflammation. Direct ARDS is associated with higher impairment of alveolar epithelium and lower impairment of capillary endothelium than indirect ARDS [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Thus, we think risk modifiers of direct and indirect ARDS should be discussed separately.</p><p id="Par17">Indeed to date, however, little has been reported about risk modifiers for ARDS among patients with non-pulmonary sepsis because a large proportion of patients with pulmonary sepsis have been included in previous studies about risk modifiers [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>].</p><p id="Par18">We aimed to evaluate the risk modifiers associated with indirect ARDS among patients with non-pulmonary sepsis.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Design and setting</title><p id="Par19">We conducted a secondary analysis of the sepsis cohort in the Focused Outcomes Research in Emergency Care in Acute Respiratory Distress Syndrome, Sepsis, and Trauma (FORECAST) study. This was a multicenter prospective cohort study of 1184 patients with severe sepsis or septic shock enrolled from 59 Intensive care units (ICUs) in Japan and conducted from January 2016 to March 2017 [<xref ref-type="bibr" rid="CR26">26</xref>].</p></sec><sec id="Sec4"><title>Participants</title><p id="Par20">We included adult patients from the FORECAST database if they were aged &#x02265;&#x02009;16 years and had severe sepsis or septic shock caused by non-pulmonary infection. The exclusion criteria were patients with missing data of the first or fourth days of ARDS screening in this study.</p></sec><sec id="Sec5"><title>Data collection</title><p id="Par21">Patient information was obtained from the FORECAST database, including demographic data, admission source, comorbidities, infection sites, sepsis-related severity scores, and laboratory data. Data collection was performed as part of the routine clinical workup by the original FORECAST investigators.</p></sec><sec id="Sec6"><title>Data definitions</title><p id="Par22">ARDS was diagnosed if present on the first or fourth day of ARDS screening, according to the Berlin ARDS definition [<xref ref-type="bibr" rid="CR27">27</xref>]. Severe sepsis and septic shock were defined based on the sepsis-2 criteria [<xref ref-type="bibr" rid="CR28">28</xref>]. Non-pulmonary infection was defined as infection other than pneumonia or empyema. Cases of DM with and without end-organ complications were reported as comorbidities. Also, &#x0201c;ventilator-free days&#x0201d; was defined as the number of days within the first 28 days after enrolment, during which a patient was able to breathe without the help of a ventilator. Patients who died during the study were assigned a ventilator-free day of 0. ICU-free days were calculated and scored in a similar manner [<xref ref-type="bibr" rid="CR29">29</xref>].</p></sec><sec id="Sec7"><title>Statistical analysis</title><p id="Par23">Patients were stratified into groups with and without ARDS (i.e., ARDS and No ARDS groups). Descriptive statistics were calculated as proportions for categorical variables and as medians (interquartile range [IQR]) or mean &#x000b1; standard deviation (SD) for continuous variables, where appropriate. Statistical differences between two groups were evaluated by univariate analyses, using the chi-square or Fisher exact tests for categorical variables and the Mann&#x02013;Whitney <italic>U</italic> test for continuous variables because the data did not have a normal distribution.</p><p id="Par24">To identify the risk modifiers correlated with having ARDS in patients with non-pulmonary sepsis, we developed a multivariate logistic regression model and reported odds ratios (ORs) with their 95% confidence intervals (CIs). We hypothesized that there could be different risk modifiers for indirect ARDS compared with those for direct ARDS reported in previous studies. The primary outcome of interest was having ARDS, and the explanatory variables were selected based on previous research: body mass index, smoking status, DM, glucocorticoids, statin, site of infection, septic shock, and acute physiology and chronic health evaluation II (APACHE II) score. We also include clinically relevant explanatory variables, such as age, gender, admission source, and coexisting conditions (e.g., congestive heart failure and chronic obstructive pulmonary disease). However, we did not take variables such as tachypnea, oxygen supplementation, acidosis, and hypoalbuminemia into the logistic regression model because these possible risk modifiers might result from ARDS. Finally, the non-pulmonary Sequential Organ Failure Assessment (SOFA) score was used in a sensitivity analysis.</p><p id="Par25">All <italic>p</italic> values were two-sided, with <italic>p</italic> values &#x0003c;&#x02009;0.05 considered statistically significant. All statistical analyses were performed using the EZR software (Version 1.32) [<xref ref-type="bibr" rid="CR30">30</xref>].</p></sec></sec><sec id="Sec8"><title>Results</title><p id="Par26">Of the 1184 patients with severe sepsis in the FORECAST study, 817 with non-pulmonary infection were eligible for this study. Another 85 patients were excluded because they had missing data of the first day of ARDS screening. This left a cohort of 69 patients with ARDS and 663 without ARDS on the first day of screening. Of those without ARDS, 35 died on the second or third day and 103 patients had missing data of the fourth day of ARDS screening, so were excluded. Finally, 594 patients with non-pulmonary sepsis were enrolled, among whom 85 (14.3%) had ARDS at the first or fourth day of ARDS screening (the ARDS group) (Fig. <xref rid="Fig1" ref-type="fig">1</xref>)
<fig id="Fig1"><label>Fig. 1</label><caption><p>Flow of patient screening and enrolment ICU intensive care unit, ARDS acute respiratory distress syndrome.</p></caption><graphic xlink:href="40560_2020_426_Fig1_HTML" id="MO1"/></fig></p><sec id="Sec9"><title>Baseline characteristics</title><p id="Par27">The median age was 72 (IQR: 62&#x02013;81) years and males accounted for 340 patients (57.2%). There were 231 patients (38.9%) with abdominal infection, 147 (24.7%) with urinary tract infection, and 91 (15.3%) with soft tissue infection. The baseline characteristics are compared between patients with and without ARDS in Table <xref rid="Tab1" ref-type="table">1</xref>.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Demographic, infection, and admission characteristics comparing those had ARDS and those did not</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Characteristics</th><th/><th>ARDS (<italic>n</italic> = 85)</th><th>No ARDS (<italic>n</italic> = 509)</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td>Age at admission&#x02014;year</td><td/><td>70 (62&#x02013;80)</td><td>72 (63&#x02013;82)</td><td>0.46</td></tr><tr><td>Male gender</td><td/><td>51 (60)</td><td>289 (56.8)</td><td>0.66</td></tr><tr><td rowspan="3">Admission source</td><td>Hospital wards and other hospitals</td><td>28 (32.9)</td><td>226 (44.5)</td><td rowspan="3">0.12</td></tr><tr><td>Emergency department</td><td>52 (61.2)</td><td>255 (50.2)</td></tr><tr><td>Intensive care unit</td><td>5 (5.9)</td><td>27 (5.3)</td></tr><tr><td>Body mass index&#x02014;kg/m<sup>2</sup></td><td/><td>23.4 &#x000b1; 4.82</td><td>23.4 &#x000b1; 5.45</td><td>0.07</td></tr><tr><td rowspan="17">Coexisting conditions</td><td>Myocardial infarction</td><td>5 (5.9)</td><td>27 (5.3)</td><td>0.80</td></tr><tr><td>Congestive heart failure</td><td>9 (10.6)</td><td>53 (10.4)</td><td>1.00</td></tr><tr><td>Peripheral vascular disease</td><td>2 (2.4)</td><td>10 (2)</td><td>0.69</td></tr><tr><td>Cerebrovascular disease</td><td>7 (8.2)</td><td>65 (12.8)</td><td>0.31</td></tr><tr><td>Dementia</td><td>4 (4.7)</td><td>44 (8.6)</td><td>0.28</td></tr><tr><td>COPD</td><td>4 (4.7)</td><td>25 (4.9)</td><td>1.00</td></tr><tr><td>Connective tissue disease</td><td>5 (5.9)</td><td>32 (6.3)</td><td>1.00</td></tr><tr><td>Peptic ulcer disease</td><td>2 (2.4)</td><td>17 (3.3)</td><td>1.00</td></tr><tr><td>Diabetes mellitus</td><td>21 (24.7)</td><td>121 (23.8)</td><td>0.96</td></tr><tr><td>Chronic kidney disease</td><td>5 (5.9)</td><td>39 (7.7)</td><td>0.66</td></tr><tr><td>Hemiplegia</td><td>2 (2.4)</td><td>20 (3.9)</td><td>0.76</td></tr><tr><td>Malignancy (solid)</td><td>6 (7.1)</td><td>68 (13.4)</td><td>0.15</td></tr><tr><td>Malignancy (blood)</td><td>1 (1.2)</td><td>9 (1.8)</td><td>1.00</td></tr><tr><td>Metastatic tumor</td><td>2 (2.4)</td><td>15 (2.9)</td><td>1.00</td></tr><tr><td>Mild liver disease</td><td>3 (3.5)</td><td>25 (4.9)</td><td>0.78</td></tr><tr><td>Moderate to severe liver disease</td><td>0 (0)</td><td>15 (2.9)</td><td>0.15</td></tr><tr><td>AIDS</td><td>0 (0)</td><td>1 (0.2)</td><td>1.00</td></tr><tr><td>CCI w/o diabetes mellitus</td><td/><td>0 (0&#x02013;1)</td><td>1 (0&#x02013;2)</td><td>0.004</td></tr><tr><td rowspan="3">Smoking</td><td>Never</td><td>55 (66.3)</td><td>275 (59.0)</td><td rowspan="3">0.05</td></tr><tr><td>Former</td><td>24 (28.9)</td><td>123 (26.4)</td></tr><tr><td>Current</td><td>4 (4.8)</td><td>68 (14.6)</td></tr><tr><td rowspan="8">Regular medication</td><td>Glucocorticoids</td><td>9 (10.6)</td><td>69 (13.6)</td><td>0.56</td></tr><tr><td>Immunosuppressants</td><td>3 (3.5)</td><td>21 (4.1)</td><td>1.00</td></tr><tr><td>Anticoagulant</td><td>13 (15.3)</td><td>42 (8.3)</td><td>0.04</td></tr><tr><td>Antiplatelet</td><td>14 (16.5)</td><td>87 (17.1)</td><td>1.00</td></tr><tr><td>Statin</td><td>5 (5.9)</td><td>53 (10.4)</td><td>0.24</td></tr><tr><td>Beta blocker</td><td>5 (5.9)</td><td>36 (7.1)</td><td>0.82</td></tr><tr><td>Anticancer drug</td><td>2 (2.4)</td><td>15 (2.9)</td><td>1.00</td></tr><tr><td>Antibiotics</td><td>16 (18.8)</td><td>70 (13.8)</td><td>0.29</td></tr><tr><td rowspan="4">Site of infection</td><td>Abdomen</td><td>32 (37.6)</td><td>199 (39.1)</td><td rowspan="4">0.25</td></tr><tr><td>Urinary tract</td><td>15 (17.6)</td><td>132 (25.9)</td></tr><tr><td>Soft tissue</td><td>17 (20.0)</td><td>74 (14.5)</td></tr><tr><td>Other than abdomen, urinary tract, or soft tissue</td><td>21 (24.7)</td><td>104 (20.4)</td></tr><tr><td>Septic shock</td><td/><td>68 (80)</td><td>336 (66)</td><td>0.02</td></tr><tr><td>Respiratory rate&#x02014;/min</td><td/><td>25 (22&#x02013;32)</td><td>24 (21&#x02013;30)</td><td>0.34</td></tr><tr><td>FiO<sub>2</sub></td><td/><td>0.4 (0.3&#x02013;0.5)</td><td>0.3 (0.25&#x02013;0.4)</td><td>&#x0003c;&#x02009;0.001</td></tr><tr><td>PaO<sub>2</sub>&#x02014;mmHg</td><td/><td>83 (75&#x02013;103)</td><td>94 (78.6&#x02013;112)</td><td>0.05</td></tr><tr><td>PaO<sub>2</sub>/FiO<sub>2</sub> ratio</td><td/><td>179 (119&#x02013;240)</td><td>284 (184&#x02013;374)</td><td>&#x0003c;&#x02009;0.001</td></tr><tr><td>Hematocrit&#x02014;%</td><td/><td>33 (28&#x02013;38)</td><td>33 (29&#x02013;39)</td><td>0.38</td></tr><tr><td>Serum albumin&#x02014;g/dL</td><td/><td>2.4 (2.0&#x02013;2.8)</td><td>2.6 (2.2&#x02013;3.2)</td><td>0.01</td></tr><tr><td>Blood pH</td><td/><td>7.36 (7.29&#x02013;7.44)</td><td>7.41 (7.34&#x02013;7.47)</td><td>0.003</td></tr><tr><td>Positive blood culture</td><td/><td>54 (63.5)</td><td>303 (59.9)</td><td>0.53</td></tr><tr><td rowspan="2">Pathogens (blood culture)</td><td>Gram positive coccus</td><td>23 (27.1)</td><td>116 (22.8)</td><td>0.39</td></tr><tr><td>Gram negative rod</td><td>28 (32.9)</td><td>167 (32.8)</td><td>0.98</td></tr><tr><td>APACHE II score</td><td/><td>26 (21&#x02013;33)</td><td>21 (16&#x02013;28)</td><td>&#x0003c;&#x02009;0.001</td></tr><tr><td>Non-pulmonary SOFA score</td><td/><td>9 (7&#x02013;11)</td><td>7 (4&#x02013;9)</td><td>&#x0003c;&#x02009;0.001</td></tr></tbody></table><table-wrap-foot><p>Reported counts (proportions) for categorical variables and median (interquartile range) for continuous variables</p><p><italic>ARDS</italic> acute respiratory distress syndrome defined by Berlin criteria, <italic>COPD</italic> chronic obstructive pulmonary disease, <italic>AIDS</italic> acquired immune deficiency syndrome, <italic>CCI</italic> Charlson Comorbidity Index, <italic>FiO</italic><sub>2</sub> fraction of inspiratory oxygen, <italic>PaO</italic><sub>2</sub> partial pressure of oxygen in arterial blood, <italic>APACHE II</italic> acute physiology and chronic health evaluation II, <italic>SOFA</italic> sequential organ failure assessment</p><p>Definition of categorical variables: other than abdomen, urinary tract, or soft tissue = central nervous system, intravenous catheter, osteoarticular, endocardium, wound, implant device, and others; positive blood culture = culture without clinically confirmed contamination; Gram-positive coccus = <italic>Staphylococcus</italic>, <italic>Streptococcus</italic>, and <italic>Enterococcus</italic>; Gram-negative rod = <italic>Acinetobacter</italic>, <italic>Aeromonas</italic>, <italic>Burkholderia</italic>, <italic>Citrobacter</italic>, <italic>Escherichia</italic>, <italic>Enterobacter</italic>, <italic>Haemophilus</italic>, <italic>Klebsiella</italic>, <italic>Legionella</italic>, <italic>Pseudomonas</italic>, <italic>Proteus</italic>, <italic>Salmonella</italic>, <italic>Serratia</italic>, <italic>Stenotrophomonas</italic>, and <italic>Vibrio</italic></p><p>Missing data (due to missing data of each outcome measures): admission source = 1; body mass index = 9; smoking = 45; respiratory rate = 1; FiO<sub>2</sub> = 14; PaO<sub>2</sub> = 18; PaO<sub>2</sub>/FiO<sub>2</sub> ratio = 19; serum albumin = 10; blood pH = 14; positive blood culture = 3; APACHE II score = 53; non-pulmonary SOFA score = 46</p></table-wrap-foot></table-wrap></p><p id="Par28">Patients with ARDS had a lower Charlson Comorbidity Index than patients without ARDS, but there were no significant differences between the groups regarding other baseline characteristics, such as age, gender, and admission source. There was no significant difference between patients with and without ARDS regarding previously known risk modifiers for direct and indirect ARDS, including body mass index, DM, smoking status, and site of infection. A higher proportion of patients had septic shock with ARDS (80%) than without ARDS (66%; <italic>p</italic> = 0.02). Compared to those without ARDS, patients with ARDS had higher severity scores assessed by the APACHE II (26 vs. 21, <italic>p</italic> &#x0003c; 0.001) and Non-pulmonary SOFA (9 vs. 7, <italic>p</italic> &#x0003c; 0.001).</p></sec><sec id="Sec10"><title>Outcomes in patients with ARDS</title><p id="Par29">In-hospital mortality in patients with and without ARDS was 29.9% and 16.5%, respectively (<italic>p</italic> = 0.007) (Table <xref rid="Tab2" ref-type="table">2</xref>). Of the 404 patients with septic shock, the in-hospital mortality rate of those with ARDS was significantly higher than that of patients without ARDS (32.8% vs. 17.9%, <italic>p</italic> = 0.01). The median ventilator-free days for patients with ARDS was less than that for patients without ARDS (15 [0&#x02013;21] vs. 22 [9&#x02013;28], <italic>p</italic> &#x0003c; 0.001), as was the median ICU-free days (14 [4&#x02013;19] vs. 19 [10&#x02013;24], <italic>p</italic> &#x0003c; 0.001). However, there was no significant difference in the length of hospital stay by ARDS status (25 [11&#x02013;61] vs. 26 [15&#x02013;51], <italic>p</italic> = 0.39). In terms of survivor dispositions, a larger proportion of patients with ARDS than without ARDS needed to be transferred to other facilities.
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Outcomes comparing patients with and without ARDS among patients with non-pulmonary sepsis</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Variable</th><th/><th>ARDS (<italic>n</italic> = 85)</th><th>No ARDS (<italic>n</italic> = 509)</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td rowspan="3">In-hospital mortality</td><td/><td>23 (29.9)</td><td>84 (16.5)</td><td>0.007</td></tr><tr><td>with septic shock (<italic>n</italic> = 404)</td><td>20 (32.8)</td><td>60 (17.9)</td><td>0.01</td></tr><tr><td>Without septic shock (<italic>n</italic> = 190)</td><td>3 (18.8)</td><td>24 (13.9)</td><td>0.71</td></tr><tr><td rowspan="2"><p>Survivor dispositions</p><p>(<italic>n</italic> = 479)</p></td><td>Home</td><td>10 (18.5)</td><td>157 (36.9)</td><td rowspan="2">0.006</td></tr><tr><td>Transfer</td><td>44 (81.5)</td><td>268 (63.1)</td></tr><tr><td>ICU-free days</td><td/><td>14 (3.75&#x02013;19.25)</td><td>19 (10&#x02013;24)</td><td>&#x0003c;&#x02009;0.001</td></tr><tr><td>Ventilator-free days</td><td/><td>15 (0&#x02013;21)</td><td>22 (8.75&#x02013;28)</td><td>&#x0003c;&#x02009;0.001</td></tr><tr><td>Length of hospital stay</td><td/><td>25 (11&#x02013;61)</td><td>26 (15&#x02013;51)</td><td>0.35</td></tr></tbody></table><table-wrap-foot><p>Reported counts (proportions) for categorical variables and median (interquartile range) for continuous variables</p><p><italic>ARDS</italic> acute respiratory distress syndrome, <italic>ICU</italic> intensive care unit</p><p>Missing data (due to missing data of each outcome measures): in-hospital mortality = 8; survivor dispositions = 0; ICU-free days = 89; ventilator-free days = 9; length of hospital stay = 8</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec11"><title>Risk modifiers for having ARDS</title><p id="Par30">In the multivariate logistic regression model, we identified three main risk modifiers associated with having ARDS (Table <xref rid="Tab3" ref-type="table">3</xref>). Notably, the odds of having ARDS were higher for patients from the emergency department than for those transferred from hospital wards or other hospitals (OR, 1.89 [1.06&#x02013;3.40]), for patients with soft tissue infection than for those with abdominal infection (OR, 2.37 [1.04&#x02013;5.40]), and for those with a higher APACHE II score (OR, 1.08 [1.05&#x02013;1.12]).
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Multivariable analysis for having ARDS associated with non-pulmonary sepsis (<italic>n</italic> = 594)</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Variable</th><th/><th>Odds ratio (95% CI)</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td>Age at admission&#x02014;per year</td><td/><td>0.99 (0.97&#x02013;1.01)</td><td>0.29</td></tr><tr><td>Male gender</td><td/><td>1.33 (0.71&#x02013;2.49)</td><td>0.37</td></tr><tr><td rowspan="3">Admission source</td><td>Hospital wards and other hospitals</td><td>Reference</td><td/></tr><tr><td>Emergency department</td><td>1.89 (1.06&#x02013;3.40)</td><td>0.03</td></tr><tr><td>Intensive care unit</td><td>0.96 (0.25&#x02013;3.65)</td><td>0.95</td></tr><tr><td>Body mass index&#x02014;kg/m<sup>2</sup></td><td/><td>1.04 (0.98&#x02013;1.09)</td><td>0.19</td></tr><tr><td rowspan="3">Smoking</td><td>Never</td><td>Reference</td><td/></tr><tr><td>Former</td><td>0.77 (0.39&#x02013;1.54)</td><td>0.46</td></tr><tr><td>Current</td><td>0.18 (0.06&#x02013;0.59)</td><td>0.004</td></tr><tr><td rowspan="3">Coexisting conditions</td><td>Congestive heart failure</td><td>0.72 (0.26&#x02013;1.88)</td><td>0.50</td></tr><tr><td>COPD</td><td>1.54 (0.46&#x02013;5.21)</td><td>0.49</td></tr><tr><td>Diabetes mellitus</td><td>0.69 (0.35&#x02013;1.37)</td><td>0.29</td></tr><tr><td rowspan="2">Regular medication</td><td>Glucocorticoids</td><td>0.48 (0.19&#x02013;1.22)</td><td>0.12</td></tr><tr><td>Statin</td><td>0.36 (0.10&#x02013;1.24)</td><td>0.11</td></tr><tr><td rowspan="4">Site of infection</td><td>Abdomen</td><td>Reference</td><td/></tr><tr><td>Urinary tract</td><td>0.71 (0.33&#x02013;1.55)</td><td>0.39</td></tr><tr><td>Soft tissue</td><td>2.37 (1.04&#x02013;5.40)</td><td>0.04</td></tr><tr><td>Other than abdomen, urinary tract, or soft tissue</td><td>1.57 (0.74&#x02013;3.32)</td><td>0.24</td></tr><tr><td>Septic shock</td><td/><td>1.43 (0.74&#x02013;2.78)</td><td>0.29</td></tr><tr><td>APACHE II score&#x02014;per point</td><td/><td>1.08 (1.05&#x02013;1.12)</td><td>&#x0003c;&#x02009;0.001</td></tr></tbody></table><table-wrap-foot><p><italic>ARDS</italic> acute respiratory distress syndrome, <italic>CI</italic> confidence interval, <italic>COPD</italic> chronic obstructive pulmonary disease, <italic>APACHE II</italic> acute physiology and chronic health evaluation II</p><p>Definition of categorical variables: other than abdomen, urinary tract, or soft tissue = central nervous system, intravenous catheter, osteoarticular, endocardium, wound, implant device, and others</p><p>Missing data (due to missing data of each outcome measures): admission source = 1; body mass index = 9; smoking = 45; APACHE II score = 53</p></table-wrap-foot></table-wrap></p></sec></sec><sec id="Sec12"><title>Discussion</title><p id="Par31">In this retrospective cohort study of patients with non-pulmonary sepsis, admission route (from the emergency department rather than wards or other hospitals), disease severity (a higher APACHE II score), and infection site (soft tissue rather than abdominal infection) were risk modifiers for non-pulmonary septic ARDS. However, obesity, DM, statins, glucocorticoids, and shock were not statistically associated with ARDS.</p><p id="Par32">Duration of onset from infection could be a valid risk modifier of ARDS in non-pulmonary sepsis. In our results, admission from the emergency department was related to having ARDS, and it is possible that both direct and indirect ARDS developed soon after or at the onset of sepsis [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Thus, ARDS may not have occurred after time had passed from admission, and further studies are needed to investigate the timing of the onset of ARDS in non-pulmonary sepsis.</p><p id="Par33">Site of infection also appeared to be a risk modifier for ARDS in non-pulmonary sepsis. One study showed that abdominal infection was related to with ARDS [<xref ref-type="bibr" rid="CR23">23</xref>], and another study showed that soft tissue infection was related to without ARDS in population that included pulmonary infection [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. The correlation with indirect ARDS in most previous studies may have been attenuated because pulmonary infection is a major predisposing condition and few studies focused on non-pulmonary infection [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. We showed that, when excluding this, soft tissue infection could be related to having ARDS. Not only pulmonary but also severe soft tissue infection could be a novel risk modifier. However, these patients were more likely to be admitted to wards instead of ICUs, presumably because shock was less common [<xref ref-type="bibr" rid="CR33">33</xref>]. By limiting our cohort to ICUs, we may have introduced some bias. It is possible that our data for site of infection reflect only disease severity, despite controlling for severity using the APACHE II score and shock status. Pathogens beyond the site of infection may also be related to having ARDS, but our sensitivity analysis did not show a difference (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). Further studies are needed to confirm which infection site is more related to developing ARDS in patients with non-pulmonary sepsis.</p><p id="Par34">We confirmed that the severity of non-pulmonary sepsis (APACHE II score) was related to having ARDS, consistent with the results in previous studies [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. In this study, we did not exclude the possibility of the pulmonary parameter of the APACHE II score representing pre-existing ARDS in the emergency department. Thus, we performed a sensitivity analysis by changing the APACHE II score with the non-pulmonary SOFA score, and it showed similar results to the main analysis (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S2). However, having shock was not related to having ARDS in our population, indicating that having ARDS in non-pulmonary sepsis might be associated with the development of multiple organ failure instead of circulatory failure (shock) [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Further studies are needed to determine organ failures that are more likely to occur with ARDS.</p><p id="Par35">We did not show roles for obesity, DM, statins, and glucocorticoids which have been shown to be risk modifiers for ARDS in previous studies. Although they were risk modifiers in direct and indirect ARDS combined, the tendencies of the ORs were similar. Otherwise, obesity may not be a risk modifier of ARDS due to non-pulmonary sepsis because of mechanism is not the same [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. DM, statin use, and glucocorticoid use have been protective against ARDS in some clinical and basic research [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR34">34</xref>], but this has not been carried through to randomized clinical trials [<xref ref-type="bibr" rid="CR35">35</xref>&#x02013;<xref ref-type="bibr" rid="CR37">37</xref>] and we found no benefits associated with the regular use of these medications. However, it is perhaps the lack of significance for the roles of obesity and smoking that was most unexpected.</p><p id="Par36">Obesity is considered a risk modifier for ARDS because patients with obesity need higher tidal volumes, positive end-expiratory pressures, and sufficiently high peak airway pressures to counter the pressure of their chest wall and abdomen [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. The lack of difference in this study may reflect our small sample size.</p><p id="Par37">Smoking has also been clearly linked as a direct risk modifier in clinical studies [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>], which is known to occur through direct damage to the alveolar epithelium that leads to local inflammation [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. Despite this, our results did not support it even indirectly, and we consider there to be two main reasons. First, smoking history may have been difficult to assess in critically ill patients. Including a combination of smoking-related biomarkers might have identified more current smokers than the smoking history obtained from patients, surrogates, and medical records [<xref ref-type="bibr" rid="CR41">41</xref>]. Second, unrecorded medication histories, including the use of inhaled corticosteroids and inhaled beta agonist may have been a confounding factor [<xref ref-type="bibr" rid="CR42">42</xref>]. It is conceivable that smoking and indirect ARDS are not associated, as is the case with smoking and direct ARDS [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Since it is difficult to consider smoking as a protective factor, we only used smoking as an adjustment factor in this study.</p><p id="Par38">Risk modifiers for ARDS among patients with non-pulmonary sepsis were similar to those reported for patients with direct and indirect ARDS in previous studies, but they were not the same. This information may help clinicians and researchers. For clinicians, it is important to carefully treat non-pulmonary sepsis particularly in patients with risk modifiers that we have shown. For researchers, it may help to develop future study design and may provide more research on which to assess risks. We recommend that more classifications or adjustments are needed for ARDS because of the large heterogeneity in the syndrome.</p><sec id="Sec13"><title>Limitations</title><p id="Par39">Several limitations of this study need to be acknowledged. First, we did not capture all ARDS episodes because we only performed screening on the first or fourth day. However, Most ARDS develops within 4 days of admission [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR15">15</xref>] and most cases occur within 12 h if sepsis is a predisposing condition [<xref ref-type="bibr" rid="CR43">43</xref>]. Second, we only included patients in ICUs, although it should be noted that most cases would have been admitted to ICUs anyway [<xref ref-type="bibr" rid="CR2">2</xref>]. Third, there could be some unmeasured confounders because of the post hoc analysis, despite using mostly the same factors as in previous studies [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Fourth, we diagnosed ARDS based on the application of the Berlin criteria by the physician in charge. Because the diagnosis of ARDS is difficult [<xref ref-type="bibr" rid="CR44">44</xref>], some cases might not have been diagnosed correctly, even if they had respiratory failure. Fifth, we assessed risk modifiers at the first day of registration, yet we know that the value of some factors might be related to timing. However, risk modifier candidates were limited to patient backgrounds and characteristics, which were fixed at data collection. Sixth, based on the results of power analysis, the sample size of this study may not have been enough for the assessment of smoking and BMI as risk modifiers. Finally, our cohort was limited to Japan [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>], and important geographic variations may have been missed [<xref ref-type="bibr" rid="CR45">45</xref>].</p></sec></sec><sec id="Sec14"><title>Conclusions</title><p id="Par40">Our retrospective cohort study from the Japanese sepsis registry revealed that admission route, severity, and infection site could be risk modifiers for ARDS in patients with non-pulmonary sepsis.</p></sec><sec sec-type="supplementary-material"><title>Supplementary information</title><sec id="Sec15"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="40560_2020_426_MOESM1_ESM.docx"><caption><p><bold>Additional file 1: Table S1.</bold> Multivariable analysis including pathogens. <bold>Table S2.</bold> Multivariable analysis including Non-pulmonary SOFA score instead of APACHE II score. Two supplementary tables contain the results of sensitivity analyses indicated in the main manuscript.</p></caption></media></supplementary-material>
</p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>APACHE</term><def><p id="Par5">Acute Physiology and Chronic Health Evaluation</p></def></def-item><def-item><term>ARDS</term><def><p id="Par6">Acute respiratory distress syndrome</p></def></def-item><def-item><term>FORECAST</term><def><p id="Par9">Focused Outcomes Research in Emergency Care in Acute Respiratory Distress Syndrome, Sepsis and Trauma</p></def></def-item><def-item><term>ICUs</term><def><p id="Par10">Intensive care units</p></def></def-item><def-item><term>OR</term><def><p id="Par12">Odds ratio</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><sec><title>Supplementary information</title><p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s40560-020-0426-9.</p></sec><ack><p>We thank the JAAM FORECAST Study Group for valuable contribution of this study.</p><p>Investigators of JAAM FORECAST Study Group: Nagasaki University Hospital (Osamu Tasaki); Osaka City University Hospital (Yasumitsu Mizobata); Tokyobay Urayasu Ichikawa Medical Center (Hiraku Funakoshi); Aso Iizuka Hospital (Toshiro Okuyama); Tomei Atsugi Hospital (Iwao Yamashita); Hiratsuka City Hospital (Toshio Kanai); National Hospital Organization Sendai Medical Center (Yasuo Yamada); Ehime University Hospital (Mayuki Aibiki); Okayama University Hospital (Keiji Sato); Tokuyama Central Hospital (Susumu Yamashita); Fukuyama City Hospital (Susumu Yamashita); JA Hiroshima General Hospital (Kenichi Yoshida); Kumamoto University Hospital (Shunji Kasaoka); Hachinohe City Hospital (Akihide Kon); Osaka City General Hospital (Hiroshi Rinka); National Hospital Organization Disaster Medical Center (Hiroshi Kato); University of Toyama (Hiroshi Okudera); Sapporo Medical University (Eichi Narimatsu); Okayama Saiseikai General Hospital (Toshifumi Fujiwara); Juntendo University Nerima Hospital (Manabu Sugita); National Hospital Organization Hokkaido Medical Center (Yasuo Shichinohe); Akita University Hospital (Hajime Nakae); Japanese Red Cross Society Kyoto Daini Hospital (Ryouji Iiduka); Maebashi Red Cross Hospital (Mitsunobu Nakamura); Sendai City Hospital (Yuji Murata); Subaru Health Insurance Society Ota Memorial Hospital (Yoshitake Sato); Fukuoka University Hospital (Hiroyasu Ishikura); Ishikawa Prefectural Central Hospital (Yasuhiro Myojo); Shiga University of Medical Science (Yasuyuki Tsujita); Nihon University School of Medicine (Kosaku Kinoshita); Seirei Yokohama General Hospital (Hiroyuki Yamaguchi); National Hospital Organization Kumamoto Medical Center (Toshihiro Sakurai); Saiseikai Utsunomiya Hospital (Satoru Miyatake); National Hospital Organization Higashi-Ohmi General Medical Center (Takao Saotome); National Hospital Organization Mito Medical Center (Susumu Yasuda); Tsukuba Medical Center Hospital (Toshikazu Abe); Osaka University Graduate School of Medicine (Hiroshi Ogura, Yutaka Umemura); Kameda Medical Center (Atsushi Shiraishi); Tohoku University Graduate School of Medicine (Shigeki Kushimoto); National Defense Medical College (Daizoh Saitoh); Keio University School of Medicine (Seitaro Fujishima, Junichi Sasaki); University of Occupational and Environmental Health (Toshihiko Mayumi); Kawasaki Medical School (Yasukazu Shiino); Chiba University Graduate School of Medicine (Taka-aki Nakada); Kyorin University School of Medicine (Takehiko Tarui); Kagawa University Hospital (Toru Hifumi); Tokyo Medical and Dental University (Yasuhiro Otomo); Hyogo College of Medicine (Joji Kotani); Saga University Hospital (Yuichiro Sakamoto); Aizu Chuo Hospital (Shin-ichiro Shiraishi); Kawasaki Municipal Kawasaki Hospital (Kiyotsugu Takuma); Yamaguchi University Hospital (Ryosuke Tsuruta); Center Hospital of the National Center for Global Health and Medicine (Akiyoshi Hagiwara); Osaka General Medical Center (Kazuma Yamakawa); Aichi Medical University Hospital (Naoshi Takeyama); Kurume University Hospital (Norio Yamashita); Teikyo University School of Medicine (Hiroto Ikeda); Rinku General Medical Center (Yasuaki Mizushima); Hokkaido University Graduate School of Medicine (Satoshi Gando)</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>HI conceived of and designed this study, interpreted the data, drafted the manuscript, and revised the manuscript for important intellectual content. TA contributed to the acquisition of data, conceived of and designed this study, interpreted the data, and revised the manuscript for important intellectual content. AS contributed to the acquisition of data, conducted data cleaning, interpreted the data, and revised the manuscript for important intellectual content. SK, HO, DS, SF, and TM, SG contributed to the acquisition of data, jointly conceived of and designed this study, interpreted the data, and revised the manuscript for important intellectual content. All authors contributed to the acquisition of data, reviewed, discussed, and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This study was supported by the JAAM (2014-01).</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></notes><notes><title>Ethics approval and consent to participate</title><p id="Par41">The study protocol was reviewed and approved by the ethics committee of all participating institutes in the Japanese Association for Acute Medicine (JAAM) study group. Institutional Review Board approval (No.014-0306) was obtained at Hokkaido University, the lead institution for FORECAST.</p></notes><notes><title>Consent for publication</title><p id="Par42">Not applicable.</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par43">The authors declare that they have no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudson</surname><given-names>LD</given-names></name><name><surname>Milberg</surname><given-names>JA</given-names></name><name><surname>Anardi</surname><given-names>D</given-names></name><name><surname>Maunder</surname><given-names>RJ</given-names></name></person-group><article-title>Clinical risks for development of the acute respiratory distress syndrome</article-title><source>Am J Respir Crit Care Med.</source><year>1995</year><volume>151</volume><fpage>293</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1164/ajrccm.151.2.7842182</pub-id><pub-id pub-id-type="pmid">7842182</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikkelsen</surname><given-names>ME</given-names></name><name><surname>Shah</surname><given-names>CV</given-names></name><name><surname>Meyer</surname><given-names>NJ</given-names></name><name><surname>Gaieski</surname><given-names>DF</given-names></name><name><surname>Lyon</surname><given-names>S</given-names></name><name><surname>Miltiades</surname><given-names>AN</given-names></name><etal/></person-group><article-title>The epidemiology of acute respiratory distress syndrome in patients presenting to the emergency department with severe sepsis</article-title><source>Shock.</source><year>2013</year><volume>40</volume><fpage>375</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1097/SHK.0b013e3182a64682</pub-id><pub-id pub-id-type="pmid">23903852</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Acute Respiratory Distress Syndrome Network</collab><name><surname>Brower</surname><given-names>RG</given-names></name><name><surname>Matthay</surname><given-names>MA</given-names></name><name><surname>Morris</surname><given-names>A</given-names></name><name><surname>Schoenfeld</surname><given-names>D</given-names></name><name><surname>Thompson</surname><given-names>BT</given-names></name><etal/></person-group><article-title>Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome</article-title><source>N Engl J Med</source><year>2000</year><volume>342</volume><fpage>1301</fpage><lpage>1308</lpage><pub-id pub-id-type="doi">10.1056/NEJM200005043421801</pub-id><pub-id pub-id-type="pmid">10793162</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brower</surname><given-names>RG</given-names></name><name><surname>Lanken</surname><given-names>PN</given-names></name><name><surname>MacIntyre</surname><given-names>N</given-names></name><name><surname>Matthay</surname><given-names>MA</given-names></name><name><surname>Morris</surname><given-names>A</given-names></name><name><surname>Ancukiewicz</surname><given-names>M</given-names></name><etal/></person-group><article-title>Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome</article-title><source>N Engl J Med.</source><year>2004</year><volume>351</volume><fpage>327</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa032193</pub-id><pub-id pub-id-type="pmid">15269312</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network</collab><name><surname>Wiedemann</surname><given-names>HP</given-names></name><name><surname>Wheeler</surname><given-names>AP</given-names></name><name><surname>Bernard</surname><given-names>GR</given-names></name><name><surname>Thompson</surname><given-names>BT</given-names></name><name><surname>Hayden</surname><given-names>D</given-names></name><etal/></person-group><article-title>Comparison of two fluid-management strategies in acute lung injury</article-title><source>N Engl J Med.</source><year>2006</year><volume>354</volume><fpage>2564</fpage><lpage>2575</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa062200</pub-id><pub-id pub-id-type="pmid">16714767</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;nez</surname><given-names>O</given-names></name><name><surname>Nin</surname><given-names>N</given-names></name><name><surname>Esteban</surname><given-names>A</given-names></name></person-group><article-title>Prone position for the treatment of acute respiratory distress syndrome: a review of current literature</article-title><source>Arch Bronconeumol.</source><year>2009</year><volume>45</volume><fpage>291</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1016/j.arbres.2008.05.010</pub-id><pub-id pub-id-type="pmid">19403223</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gattinoni</surname><given-names>L</given-names></name><name><surname>Carlesso</surname><given-names>E</given-names></name><name><surname>Taccone</surname><given-names>P</given-names></name><name><surname>Polli</surname><given-names>F</given-names></name><name><surname>Gu&#x000e9;rin</surname><given-names>C</given-names></name><name><surname>Mancebo</surname><given-names>J</given-names></name></person-group><article-title>Prone positioning improves survival in severe ARDS: a pathophysiologic review and individual patient meta-analysis</article-title><source>Minerva Anestesiol.</source><year>2010</year><volume>76</volume><fpage>448</fpage><lpage>454</lpage><pub-id pub-id-type="pmid">20473258</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papazian</surname><given-names>L</given-names></name><name><surname>Forel</surname><given-names>JM</given-names></name><name><surname>Gacouin</surname><given-names>A</given-names></name><name><surname>Penot-Ragon</surname><given-names>C</given-names></name><name><surname>Perrin</surname><given-names>G</given-names></name><name><surname>Loundou</surname><given-names>A</given-names></name><etal/></person-group><article-title>Neuromuscular blockers in early acute respiratory distress syndrome</article-title><source>N Engl J Med.</source><year>2010</year><volume>363</volume><fpage>1107</fpage><lpage>1116</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1005372</pub-id><pub-id pub-id-type="pmid">20843245</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peek</surname><given-names>GJ</given-names></name><name><surname>Mugford</surname><given-names>M</given-names></name><name><surname>Tiruvoipati</surname><given-names>R</given-names></name><name><surname>Wilson</surname><given-names>A</given-names></name><name><surname>Allen</surname><given-names>E</given-names></name><name><surname>Thalanany</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (Cesar): a multicentre randomised controlled trial</article-title><source>Lancet.</source><year>2009</year><volume>374</volume><fpage>1351</fpage><lpage>1363</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(09)61069-2</pub-id><pub-id pub-id-type="pmid">19762075</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levitt</surname><given-names>JE</given-names></name><name><surname>Matthay</surname><given-names>MA</given-names></name></person-group><article-title>Clinical review: early treatment of acute lung injury&#x02014;paradigm shift toward prevention and treatment prior to respiratory failure</article-title><source>Crit Care.</source><year>2012</year><volume>16</volume><fpage>223</fpage><pub-id pub-id-type="doi">10.1186/cc11144</pub-id><pub-id pub-id-type="pmid">22713281</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>MN</given-names></name><name><surname>Thompson</surname><given-names>BT</given-names></name><name><surname>Williams</surname><given-names>P</given-names></name><name><surname>Pothier</surname><given-names>L</given-names></name><name><surname>Boyce</surname><given-names>PD</given-names></name><name><surname>Christiani</surname><given-names>DC</given-names></name></person-group><article-title>Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion</article-title><source>Crit Care Med.</source><year>2005</year><volume>33</volume><fpage>1191</fpage><lpage>1198</lpage><pub-id pub-id-type="doi">10.1097/01.CCM.0000165566.82925.14</pub-id><pub-id pub-id-type="pmid">15942330</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>ND</given-names></name><name><surname>Frutos-Vivar</surname><given-names>F</given-names></name><name><surname>Esteban</surname><given-names>A</given-names></name><name><surname>Gordo</surname><given-names>F</given-names></name><name><surname>Honrubia</surname><given-names>T</given-names></name><name><surname>Pe&#x000f1;uelas</surname><given-names>O</given-names></name><etal/></person-group><article-title>Clinical risk conditions for acute lung injury in the intensive care unit and hospital ward: a prospective observational study</article-title><source>Crit Care.</source><year>2007</year><volume>11</volume><fpage>R96</fpage><pub-id pub-id-type="doi">10.1186/cc6113</pub-id><pub-id pub-id-type="pmid">17784960</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seethala</surname><given-names>RR</given-names></name><name><surname>Hou</surname><given-names>PC</given-names></name><name><surname>Aisiku</surname><given-names>IP</given-names></name><name><surname>Frendl</surname><given-names>G</given-names></name><name><surname>Park</surname><given-names>PK</given-names></name><name><surname>Mikkelsen</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Early risk factors and the role of fluid administration in developing acute respiratory distress syndrome in septic patients</article-title><source>Ann Intensive Care.</source><year>2017</year><volume>7</volume><fpage>11</fpage><pub-id pub-id-type="doi">10.1186/s13613-017-0233-1</pub-id><pub-id pub-id-type="pmid">28116595</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trillo-Alvarez</surname><given-names>C</given-names></name><name><surname>Cartin-Ceba</surname><given-names>R</given-names></name><name><surname>Kor</surname><given-names>DJ</given-names></name><name><surname>Kojicic</surname><given-names>M</given-names></name><name><surname>Kashyap</surname><given-names>R</given-names></name><name><surname>Thakur</surname><given-names>S</given-names></name><etal/></person-group><article-title>Acute lung injury prediction score: derivation and validation in a population-based sample</article-title><source>Eur Respir J.</source><year>2011</year><volume>37</volume><fpage>604</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1183/09031936.00036810</pub-id><pub-id pub-id-type="pmid">20562130</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gajic</surname><given-names>O</given-names></name><name><surname>Dabbagh</surname><given-names>O</given-names></name><name><surname>Park</surname><given-names>PK</given-names></name><name><surname>Adesanya</surname><given-names>A</given-names></name><name><surname>Chang</surname><given-names>SY</given-names></name><name><surname>Hou</surname><given-names>P</given-names></name><etal/></person-group><article-title>Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study</article-title><source>Am J Respir Crit Care Med.</source><year>2011</year><volume>183</volume><fpage>462</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1164/rccm.201004-0549OC</pub-id><pub-id pub-id-type="pmid">20802164</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>MN</given-names></name><name><surname>Bajwa</surname><given-names>EK</given-names></name><name><surname>Thompson</surname><given-names>BT</given-names></name><name><surname>Christiani</surname><given-names>DC</given-names></name></person-group><article-title>Body mass index is associated with the development of acute respiratory distress syndrome</article-title><source>Thorax.</source><year>2010</year><volume>65</volume><fpage>44</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1136/thx.2009.117572</pub-id><pub-id pub-id-type="pmid">19770169</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calfee</surname><given-names>CS</given-names></name><name><surname>Matthay</surname><given-names>MA</given-names></name><name><surname>Kangelaris</surname><given-names>KN</given-names></name><name><surname>Siew</surname><given-names>ED</given-names></name><name><surname>Janz</surname><given-names>DR</given-names></name><name><surname>Bernard</surname><given-names>GR</given-names></name><etal/></person-group><article-title>Cigarette smoke exposure and the acute respiratory distress syndrome</article-title><source>Crit Care Med.</source><year>2015</year><volume>43</volume><fpage>1790</fpage><lpage>1797</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000001089</pub-id><pub-id pub-id-type="pmid">26010690</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toy</surname><given-names>P</given-names></name><name><surname>Bacchetti</surname><given-names>P</given-names></name><name><surname>Grimes</surname><given-names>B</given-names></name><name><surname>Gajic</surname><given-names>O</given-names></name><name><surname>Murphy</surname><given-names>EL</given-names></name><name><surname>Winters</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Recipient clinical risk factors predominate in possible transfusion-related acute lung injury</article-title><source>Transfusion.</source><year>2015</year><volume>55</volume><fpage>947</fpage><lpage>952</lpage><pub-id pub-id-type="doi">10.1111/trf.12954</pub-id><pub-id pub-id-type="pmid">25488517</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname><given-names>AJ</given-names></name><name><surname>Madotto</surname><given-names>F</given-names></name><name><surname>Laffey</surname><given-names>JG</given-names></name><name><surname>Bellani</surname><given-names>G</given-names></name><name><surname>Pham</surname><given-names>T</given-names></name><name><surname>Pesenti</surname><given-names>A</given-names></name><etal/></person-group><article-title>Identifying associations between diabetes and acute respiratory distress syndrome in patients with acute hypoxemic respiratory failure: an analysis of the LUNG SAFE database</article-title><source>Crit Care.</source><year>2018</year><volume>22</volume><fpage>268</fpage><pub-id pub-id-type="doi">10.1186/s13054-018-2158-y</pub-id><pub-id pub-id-type="pmid">30367670</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peter</surname><given-names>JV</given-names></name><name><surname>John</surname><given-names>P</given-names></name><name><surname>Graham</surname><given-names>PL</given-names></name><name><surname>Moran</surname><given-names>JL</given-names></name><name><surname>George</surname><given-names>IA</given-names></name><name><surname>Bersten</surname><given-names>A</given-names></name></person-group><article-title>Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis</article-title><source>BMJ.</source><year>2008</year><volume>336</volume><fpage>1006</fpage><lpage>1009</lpage><pub-id pub-id-type="doi">10.1136/bmj.39537.939039.BE</pub-id><pub-id pub-id-type="pmid">18434379</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobson</surname><given-names>JR</given-names></name><name><surname>Barnard</surname><given-names>JW</given-names></name><name><surname>Grigoryev</surname><given-names>DN</given-names></name><name><surname>Ma</surname><given-names>SF</given-names></name><name><surname>Tuder</surname><given-names>RM</given-names></name><name><surname>Garcia</surname><given-names>JG</given-names></name></person-group><article-title>Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury</article-title><source>Am J Physiol Lung Cell Mol Physiol.</source><year>2005</year><volume>288</volume><fpage>L1026</fpage><lpage>L1032</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00354.2004</pub-id><pub-id pub-id-type="pmid">15665042</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shyamsundar</surname><given-names>M</given-names></name><name><surname>McKeown</surname><given-names>ST</given-names></name><name><surname>O'Kane</surname><given-names>CM</given-names></name><name><surname>Craig</surname><given-names>TR</given-names></name><name><surname>Brown</surname><given-names>V</given-names></name><name><surname>Thickett</surname><given-names>DR</given-names></name><etal/></person-group><article-title>Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers</article-title><source>Am J Respir Crit Care Med.</source><year>2009</year><volume>179</volume><fpage>1107</fpage><lpage>1114</lpage><pub-id pub-id-type="doi">10.1164/rccm.200810-1584OC</pub-id><pub-id pub-id-type="pmid">19324974</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheu</surname><given-names>CC</given-names></name><name><surname>Gong</surname><given-names>MN</given-names></name><name><surname>Zhai</surname><given-names>R</given-names></name><name><surname>Bajwa</surname><given-names>EK</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Thompson</surname><given-names>BT</given-names></name><etal/></person-group><article-title>The influence of infection sites on development and mortality of ARDS</article-title><source>Intensive Care Med.</source><year>2010</year><volume>36</volume><fpage>963</fpage><lpage>970</lpage><pub-id pub-id-type="doi">10.1007/s00134-010-1851-3</pub-id><pub-id pub-id-type="pmid">20229040</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levitt</surname><given-names>JE</given-names></name><name><surname>Bedi</surname><given-names>H</given-names></name><name><surname>Calfee</surname><given-names>CS</given-names></name><name><surname>Gould</surname><given-names>MK</given-names></name><name><surname>Matthay</surname><given-names>MA</given-names></name></person-group><article-title>Identification of early acute lung injury at initial evaluation in an acute care setting prior to the onset of respiratory failure</article-title><source>Chest.</source><year>2009</year><volume>135</volume><fpage>936</fpage><lpage>943</lpage><pub-id pub-id-type="doi">10.1378/chest.08-2346</pub-id><pub-id pub-id-type="pmid">19188549</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calfee</surname><given-names>CS</given-names></name><name><surname>Janz</surname><given-names>DR</given-names></name><name><surname>Bernard</surname><given-names>GR</given-names></name><name><surname>May</surname><given-names>AK</given-names></name><name><surname>Kangelaris</surname><given-names>KN</given-names></name><name><surname>Matthay</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies</article-title><source>Chest.</source><year>2015</year><volume>147</volume><fpage>1539</fpage><lpage>1548</lpage><pub-id pub-id-type="doi">10.1378/chest.14-2454</pub-id><pub-id pub-id-type="pmid">26033126</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>T</given-names></name><name><surname>Ogura</surname><given-names>H</given-names></name><name><surname>Shiraishi</surname><given-names>A</given-names></name><name><surname>Kushimoto</surname><given-names>S</given-names></name><name><surname>Saitoh</surname><given-names>D</given-names></name><name><surname>Fujishima</surname><given-names>S</given-names></name><etal/></person-group><article-title>Characteristics, management, and in-hospital mortality among patients with severe sepsis in intensive care units in Japan: the FORECAST study</article-title><source>Crit Care.</source><year>2018</year><volume>22</volume><fpage>322</fpage><pub-id pub-id-type="doi">10.1186/s13054-018-2186-7</pub-id><pub-id pub-id-type="pmid">30466493</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="other">ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al<italic>.</italic> Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526-2533.</mixed-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>MM</given-names></name><name><surname>Fink</surname><given-names>MP</given-names></name><name><surname>Marshall</surname><given-names>JC</given-names></name><name><surname>Abraham</surname><given-names>E</given-names></name><name><surname>Angus</surname><given-names>D</given-names></name><name><surname>Cook</surname><given-names>D</given-names></name><etal/></person-group><article-title>2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference</article-title><source>Crit Care Med.</source><year>2003</year><volume>31</volume><fpage>1250</fpage><lpage>1256</lpage><pub-id pub-id-type="doi">10.1097/01.CCM.0000050454.01978.3B</pub-id><pub-id pub-id-type="pmid">12682500</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girard</surname><given-names>TD</given-names></name><name><surname>Kress</surname><given-names>JP</given-names></name><name><surname>Fuchs</surname><given-names>BD</given-names></name><name><surname>Thomason</surname><given-names>JW</given-names></name><name><surname>Schweickert</surname><given-names>WD</given-names></name><name><surname>Pun</surname><given-names>BT</given-names></name><etal/></person-group><article-title>Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial</article-title><source>Lancet.</source><year>2008</year><volume>371</volume><fpage>126</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(08)60105-1</pub-id><pub-id pub-id-type="pmid">18191684</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanda</surname><given-names>Y</given-names></name></person-group><article-title>Investigation of the freely available easy-to-use software 'EZR' for medical statistics</article-title><source>Bone Marrow Transplant.</source><year>2013</year><volume>48</volume><fpage>452</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1038/bmt.2012.244</pub-id><pub-id pub-id-type="pmid">23208313</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nam</surname><given-names>H</given-names></name><name><surname>Jang</surname><given-names>SH</given-names></name><name><surname>Hwang</surname><given-names>YI</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Park</surname><given-names>JY</given-names></name><name><surname>Park</surname><given-names>S</given-names></name></person-group><article-title>Nonpulmonary risk factors of acute respiratory distress syndrome in patients with septic bacteraemia</article-title><source>Korean J Intern Med.</source><year>2019</year><volume>34</volume><fpage>116</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.3904/kjim.2017.204</pub-id><pub-id pub-id-type="pmid">29898577</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujishima</surname><given-names>S</given-names></name><name><surname>Gando</surname><given-names>S</given-names></name><name><surname>Daizoh</surname><given-names>S</given-names></name><name><surname>Kushimoto</surname><given-names>S</given-names></name><name><surname>Ogura</surname><given-names>H</given-names></name><name><surname>Mayumi</surname><given-names>T</given-names></name><etal/></person-group><article-title>Infection site is predictive of outcome in acute lung injury associated with severe sepsis and septic shock</article-title><source>Respirology.</source><year>2016</year><volume>21</volume><fpage>898</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.1111/resp.12769</pub-id><pub-id pub-id-type="pmid">27028604</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>T</given-names></name><name><surname>Ogura</surname><given-names>H</given-names></name><name><surname>Kushimoto</surname><given-names>S</given-names></name><name><surname>Shiraishi</surname><given-names>A</given-names></name><name><surname>Sugiyama</surname><given-names>T</given-names></name><name><surname>Deshpande</surname><given-names>GA</given-names></name><etal/></person-group><article-title>Variations in infection sites and mortality rates among patients in intensive care units with severe sepsis and septic shock in Japan</article-title><source>J Intensive Care.</source><year>2019</year><volume>7</volume><fpage>28</fpage><pub-id pub-id-type="doi">10.1186/s40560-019-0383-3</pub-id><pub-id pub-id-type="pmid">31073407</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moss</surname><given-names>M</given-names></name><name><surname>Guidot</surname><given-names>DM</given-names></name><name><surname>Steinberg</surname><given-names>KP</given-names></name><name><surname>Duhon</surname><given-names>GF</given-names></name><name><surname>Treece</surname><given-names>P</given-names></name><name><surname>Wolken</surname><given-names>R</given-names></name><etal/></person-group><article-title>Diabetic patients have a decreased incidence of acute respiratory distress syndrome</article-title><source>Crit Care Med.</source><year>2000</year><volume>28</volume><fpage>2187</fpage><lpage>2192</lpage><pub-id pub-id-type="doi">10.1097/00003246-200007000-00001</pub-id><pub-id pub-id-type="pmid">10921539</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Annane</surname><given-names>D</given-names></name><name><surname>S&#x000e9;bille</surname><given-names>V</given-names></name><name><surname>Bellissant</surname><given-names>E</given-names></name><collab>Ger-Inf-05 Study Group</collab></person-group><article-title>Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome</article-title><source>Crit Care Med.</source><year>2006</year><volume>34</volume><fpage>22</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1097/01.CCM.0000194723.78632.62</pub-id><pub-id pub-id-type="pmid">16374152</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McAuley</surname><given-names>DF</given-names></name><name><surname>Laffey</surname><given-names>JG</given-names></name><name><surname>O'Kane</surname><given-names>CM</given-names></name><name><surname>Perkins</surname><given-names>GD</given-names></name><name><surname>Mullan</surname><given-names>B</given-names></name><name><surname>Trinder</surname><given-names>TJ</given-names></name><etal/></person-group><article-title>Simvastatin in the acute respiratory distress syndrome</article-title><source>N Engl J Med.</source><year>2014</year><volume>371</volume><fpage>1695</fpage><lpage>1703</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1403285</pub-id><pub-id pub-id-type="pmid">25268516</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>National Heart, Lung, and Blood Institute ARDS Clinical Trials Network</collab><name><surname>Truwit</surname><given-names>JD</given-names></name><name><surname>Bernard</surname><given-names>GR</given-names></name><name><surname>Steingrub</surname><given-names>J</given-names></name><name><surname>Matthay</surname><given-names>MA</given-names></name><name><surname>Liu</surname><given-names>KD</given-names></name><etal/></person-group><article-title>Rosuvastatin for sepsis-associated acute respiratory distress syndrome</article-title><source>N Engl J Med</source><year>2014</year><volume>370</volume><fpage>2191</fpage><lpage>2200</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1401520</pub-id><pub-id pub-id-type="pmid">24835849</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Brien</surname><given-names>JM</given-names><suffix>Jr</suffix></name><name><surname>Welsh</surname><given-names>CH</given-names></name><name><surname>Fish</surname><given-names>RH</given-names></name><name><surname>Ancukiewicz</surname><given-names>M</given-names></name><name><surname>Kramer</surname><given-names>AM</given-names></name><collab>National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network</collab><etal/></person-group><source>Ann Intern Med</source><year>2004</year><volume>140</volume><fpage>338</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-140-5-200403020-00009</pub-id><pub-id pub-id-type="pmid">14996675</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirsch</surname><given-names>J</given-names></name><name><surname>Chalkley</surname><given-names>RJ</given-names></name><name><surname>Bentley</surname><given-names>T</given-names></name><name><surname>Burlingame</surname><given-names>AL</given-names></name><name><surname>Frank</surname><given-names>JA</given-names></name></person-group><article-title>Double impact of cigarette smoke and mechanical ventilation on the alveolar epithelial type II cell</article-title><source>Crit Care.</source><year>2014</year><volume>18</volume><fpage>R50</fpage><pub-id pub-id-type="doi">10.1186/cc13795</pub-id><pub-id pub-id-type="pmid">24666941</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Checa</surname><given-names>M</given-names></name><name><surname>Hagood</surname><given-names>JS</given-names></name><name><surname>Velazquez-Cruz</surname><given-names>R</given-names></name><name><surname>Ruiz</surname><given-names>V</given-names></name><name><surname>Garc&#x000ed;a-De-Alba</surname><given-names>C</given-names></name><name><surname>Rangel-Escare&#x000f1;o</surname><given-names>C</given-names></name><etal/></person-group><article-title>Cigarette smoke enhances the expression of profibrotic molecules in alveolar epithelial cells</article-title><source>Plos One.</source><year>2016</year><volume>11</volume><fpage>e0150383</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0150383</pub-id><pub-id pub-id-type="pmid">26934369</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>SJ</given-names></name><name><surname>Ware</surname><given-names>LB</given-names></name><name><surname>Eisner</surname><given-names>MD</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Jacob</surname><given-names>P</given-names><suffix>3rd</suffix></name><name><surname>Havel</surname><given-names>C</given-names></name><etal/></person-group><article-title>Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients</article-title><source>Crit Care Med.</source><year>2011</year><volume>39</volume><fpage>40</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1097/CCM.0b013e3181fa4196</pub-id><pub-id pub-id-type="pmid">20935560</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Festic</surname><given-names>E</given-names></name><name><surname>Carr</surname><given-names>GE</given-names></name><name><surname>Cartin-Ceba</surname><given-names>R</given-names></name><name><surname>Hinds</surname><given-names>RF</given-names></name><name><surname>Banner-Goodspeed</surname><given-names>V</given-names></name><name><surname>Bansal</surname><given-names>V</given-names></name><etal/></person-group><article-title>Randomized clinical trial of a combination of an inhaled corticosteroid and beta agonist in patients at risk of developing the acute respiratory distress syndrome</article-title><source>Crit Care Med.</source><year>2017</year><volume>45</volume><fpage>798</fpage><lpage>805</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000002284</pub-id><pub-id pub-id-type="pmid">28240689</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iscimen</surname><given-names>R</given-names></name><name><surname>Cartin-Ceba</surname><given-names>R</given-names></name><name><surname>Yilmaz</surname><given-names>M</given-names></name><name><surname>Khan</surname><given-names>H</given-names></name><name><surname>Hubmayr</surname><given-names>RD</given-names></name><name><surname>Afessa</surname><given-names>B</given-names></name><etal/></person-group><article-title>Risk factors for the development of acute lung injury in patients with septic shock: an observational cohort study</article-title><source>Crit Care Med.</source><year>2008</year><volume>36</volume><fpage>1518</fpage><lpage>1522</lpage><pub-id pub-id-type="doi">10.1097/CCM.0b013e31816fc2c0</pub-id><pub-id pub-id-type="pmid">18434908</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellani</surname><given-names>G</given-names></name><name><surname>Laffey</surname><given-names>JG</given-names></name><name><surname>Pham</surname><given-names>T</given-names></name><name><surname>Fan</surname><given-names>E</given-names></name><name><surname>Brochard</surname><given-names>L</given-names></name><name><surname>Esteban</surname><given-names>A</given-names></name><etal/></person-group><article-title>Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries</article-title><source>JAMA.</source><year>2016</year><volume>315</volume><fpage>788</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1001/jama.2016.0291</pub-id><pub-id pub-id-type="pmid">26903337</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villar</surname><given-names>J</given-names></name><name><surname>Blanco</surname><given-names>J</given-names></name><name><surname>A&#x000f1;&#x000f3;n</surname><given-names>JM</given-names></name><name><surname>Santos-Bouza</surname><given-names>A</given-names></name><name><surname>Blanch</surname><given-names>L</given-names></name><name><surname>Ambr&#x000f3;s</surname><given-names>A</given-names></name><etal/></person-group><article-title>The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation</article-title><source>Intensive Care Med.</source><year>2011</year><volume>37</volume><fpage>1932</fpage><lpage>1941</lpage><pub-id pub-id-type="doi">10.1007/s00134-011-2380-4</pub-id><pub-id pub-id-type="pmid">21997128</pub-id></element-citation></ref></ref-list></back></article>